Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	Placebo- Female Participants	23
Overall Study	STARTED	GSK2881078 1.0 mg- Female Participants	24
Overall Study	STARTED	Placebo- Male Participants	24
Overall Study	STARTED	GSK2881078 2.0 mg- Male Participants	25
Overall Study	COMPLETED	Placebo- Female Participants	21
Overall Study	COMPLETED	GSK2881078 1.0 mg- Female Participants	18
Overall Study	COMPLETED	Placebo- Male Participants	18
Overall Study	COMPLETED	GSK2881078 2.0 mg- Male Participants	20
Overall Study	NOT COMPLETED	Placebo- Female Participants	2
Overall Study	NOT COMPLETED	GSK2881078 1.0 mg- Female Participants	6
Overall Study	NOT COMPLETED	Placebo- Male Participants	6
Overall Study	NOT COMPLETED	GSK2881078 2.0 mg- Male Participants	5

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03359473/flow